Loading the map…
Development of building projects · Gloucester
Oaksmith Building
Oaksmith Building Ltd
Private limited company registered in Gloucester, classed under “Development of building projects” and 1 other activity.
Headline figures
FY to Jun 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
2 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2024 | 2025 |
|---|---|---|
| Profit after tax | — | |
| Turnover | ||
| Net assets | ||
| Cash | ||
| Employees | ||
| Retained reserves |
Every figure for all 2 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2024 | 2025 |
|---|---|---|
| Fixed assets | ||
| Current assets | ||
| of which debtors | ||
| of which cash | ||
| Net current assets | ||
| Net assets |
6 balance-sheet lines, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does Oaksmith Building do?
Private limited company registered in Gloucester, classed under “Development of building projects” and 1 other activity.
›How much turnover does Oaksmith Building make?
Answered in the full report
›Is Oaksmith Building profitable?
Oaksmith Building's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Oaksmith Building?
Answered in the full report
›Where is Oaksmith Building based?
Its registered office is 46 Brookfield Road, Hucclecote, Gloucester, GL3 3HG, in Gloucester.
›When was Oaksmith Building founded?
Oaksmith Building Ltd was incorporated on 26 June 2023.
›Is Oaksmith Building still trading?
The register lists Oaksmith Building Ltd as active.